Actively Recruiting
Assessing the Burden of Respiratory Syncytial Virus Infection in Adults in Hong Kong Through Observational Study
Led by Chinese University of Hong Kong · Updated on 2026-09-01
10000
Participants Needed
1
Research Sites
23 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the burden of respiratory syncytial virus RSV infection among adults in Hong Kong, where RSV causes significant illness and death. Although much is known about RSV in infants and young children, there is limited data on its impact in adults, especially older adults and those with other health conditions. This study aims to fill knowledge gaps by prospectively assessing how RSV affects adults, including its incidence, severity, and related healthcare costs. The study involves observing adults aged 18 and older who have symptoms of respiratory tract infection. Participants will be divided into two groups those confirmed to have RSV infection and those without RSV. For patients with RSV, serial samples will be collected from the nasopharynx, saliva, and sputum on days 3, 5, 7, 14, and 28 during hospitalization, and blood will be taken on day 28 for serology testing. These procedures aim to detect and monitor RSV viral presence and immune response. Participants will be monitored over one month to measure how often RSV infection occurs and how often severe RSV illness develops. Researchers will collect respiratory samples, blood for antibody testing, and clinical information to understand the disease burden better. The study will help estimate the incidence of RSV and related healthcare costs in adults. It is observational, so participants receive usual care while contributing data to the study. Monitoring includes specimen collection during hospitalization and follow-up assessments up to 28 days.
CONDITIONS
Brief Title
RSV Burden in Hong Kong
Research Team
K
Ka Pang Chan, MBChB
K
Karen Yiu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here